Afidro warned about the continuity of medicines and treatments after the Government's emergency plan: it asked to recover $3 trillion for health in 2027

The Association of Pharmaceutical Research and Development Laboratories (Afidro) has warned about the future continuity of medications and treatments following the Colombian government's shock plan for the healthcare sector. In response to the administration's measures, the organization has called for the recovery of three trillion pesos in funding allocated for health within the 2027 General National Budget.

The intervention by Afidro highlights ongoing concerns from pharmaceutical industry representatives regarding financial planning and resource allocation for public health. The association stresses that restoring these specific budgetary allocations is essential to maintaining stable medical supplies and patient care standards over the coming years.